Diabetes

Higher urine alpha-1-microglobulin concentration may be associated with incident chronic kidney disease in patients without prevalent CKD or diabetes, according to published data.

The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.

Adults with obstructive sleep apnea had elevated odds of developing various heart-related health conditions compared with those without it, and the association was strongest in younger individuals, researchers reported.

Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal Medicine.

Teva Pharmaceuticals launched the first generic GLP-1 receptor agonist, liraglutide 1.8 mg, for patients aged 10 years or older with type 2 diabetes.

Women with type 2 diabetes diagnosed with hypertension at younger than age 50 years have an increased risk for cardiovascular disease and could benefit from intensive antihypertension therapy according to data published in Diabetes Care.

Matrix metalloproteinase 2 may be associated with the progression of chronic kidney disease, especially in patients with low inflammation or with proteinuria, data show.

AI in diabetes care is becoming more popular with various potential benefits for patients and clinicians as well as important challenges to keep in mind, according to a conversation between two diabetes experts.

ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about the importance of not worsening disparities with the implementation of AI in diabetes care.

ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about important considerations for using AI in clinical practice.